US CDC panel recommends Sanofi-AstraZeneca’s preventive RSV therapy for babies Therapeutics The therapy, branded as Beyfortus, will be available in the U.S. ahead of the upcoming 2023-24 RSV season, Sanofi said. Read more August 3, 2023/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/04/Sanofi-logo.webp 800 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2023-08-03 19:30:152023-08-04 08:38:17US CDC panel recommends Sanofi-AstraZeneca's preventive RSV therapy for babies
